The company has achieved a fortress balance sheet, compressing its debt-to-equity ratio from 0.31 in 2023Q4 to a negligible 0.03 as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 388.94M | 365.61M | 313.77M | 314.24M | 335.8M | 322.23M | 266.89M | 254.95M | 226.31M | 199.34M | 188.44M | 198.83M | 181.3M | 277.77M | 211.91M | 175.74M | 129.65M | 93.01M | 55.25M | 52.47M | 28.86M | 35.27M | 29.21M | 23.63M | 18.81M | 17.02M | 11.37M | 9.1M | 8.4M | 7.3M | 5.6M |
| Cash & Short-Term Investments | 72.87M | 74.57M | 49.52M | 64.45M | 66.56M | 103.24M | 84.57M | 65.67M | 54.27M | 40.42M | 38.64M | 84.8M | 50.29M | 208.75M | 144.74M | 114.78M | 77.25M | 46.43M | 3.42M | 2.31M | 5.19M | 13M | 12.73M | 9.24M | 1.73M | 3.12M | 3.07M | 1.7M | 1.3M | 700K | 100K |
| Cash Only | 72.87M | 74.57M | 49.52M | 64.45M | 66.56M | 103.24M | 84.57M | 65.67M | 54.27M | 40.42M | 38.64M | 84.8M | 50.29M | 208.75M | 144.74M | 114.78M | 77.25M | 46.43M | 3.42M | 2.31M | 5.19M | 13M | 12.73M | 9.24M | 1.73M | 3.12M | 3.07M | 1.7M | 1.3M | 700K | 100K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 154.23M | 143.6M | 119.66M | 125.28M | 131.58M | 117.41M | 98.21M | 93.44M | 99.55M | 91.23M | 83.25M | 60.48M | 71.98M | 39.39M | 42M | 34.43M | 32.05M | 29.15M | 30.25M | 29.64M | 11.58M | 11.52M | 8M | 7.23M | 7.16M | 7.13M | 5.04M | 4M | 3.3M | 3.1M | 3M |
| Days Sales Outstanding | 48.79 | 50.53 | 45.8 | 49.57 | 50.96 | 53.63 | 50.95 | 52.99 | 56.45 | 55.98 | 54.93 | 39.96 | 48.53 | 42.64 | 49.39 | 43.06 | 45.86 | 48.48 | 47.58 | 61.4 | 41.88 | 5.01 | 43.3 | 42.67 | 43.41 | 56.4 | 55.46 | 49.16 | 41.97 | 39.56 | 41.48 |
| Inventory | 146.74M | 131.45M | 130.8M | 109.52M | 119.67M | 91.06M | 70.62M | 83.89M | 67.19M | 60.7M | 57.24M | 46.09M | 49.62M | 24.82M | 20.69M | 18.64M | 15.72M | 13.96M | 16.62M | 15.68M | 9.92M | 8.54M | 6.32M | 5.96M | 7.24M | 5.58M | 2.55M | 2.7M | 2.9M | 2.5M | 1.9M |
| Days Inventory Outstanding | 75.67 | 71.98 | 77.32 | 64.44 | 65.99 | 59.79 | 53.73 | 70.83 | 55.81 | 54.6 | 56.12 | 43.76 | 45.6 | 37.79 | 34.2 | 33.04 | 32.41 | 33.43 | 33.8 | 44.27 | 54.11 | 57.28 | 52.9 | 53.43 | 71.62 | 72.12 | 54.38 | 63.17 | 67.85 | 59.64 | 50.62 |
| Other Current Assets | 15.09M | 16M | 5.74M | 7.19M | 13.09M | 4.41M | 3.44M | 7.55M | 1.48M | 2.22M | 5.19M | 3.72M | 4.87M | 2.24M | 1.11M | 954K | 1.1M | 1.42M | 2.38M | 2.39M | 416K | 276K | 321K | 474K | 403K | 214K | 200K | 700K | 900K | 1M | 600K |
| Total Non-Current Assets | 1.3B | 1.34B | 1.26B | 1.28B | 1.29B | 877.09M | 898.96M | 900.74M | 755.04M | 764.3M | 760.18M | 682.39M | 679.97M | 99.1M | 100.64M | 95.98M | 98.97M | 94.8M | 99.22M | 101.95M | 63.48M | 39.88M | 31.19M | 33.28M | 34.49M | 27.45M | 11.85M | 12.9M | 14.2M | 10.3M | 9.5M |
| Property, Plant & Equipment | 318.2M | 322.84M | 299.2M | 295.9M | 290.79M | 246.81M | 236.51M | 224.2M | 194.34M | 189.79M | 165.75M | 158.51M | 131.59M | 54.92M | 52.73M | 44.28M | 43.39M | 41.58M | 42.51M | 42.08M | 31.31M | 24.4M | 24.19M | 25.64M | 25.85M | 17.9M | 7.76M | 7.8M | 8.1M | 7.3M | 7.5M |
| Fixed Asset Turnover | 3.35x | 3.21x | 3.19x | 3.12x | 3.24x | 3.24x | 2.98x | 2.87x | 3.31x | 3.13x | 3.34x | 3.49x | 4.11x | 6.14x | 5.89x | 6.59x | 5.88x | 5.28x | 5.46x | 4.19x | 3.22x | 34.39x | 2.79x | 2.41x | 2.33x | 2.58x | 4.28x | 3.81x | 3.54x | 3.92x | 3.52x |
| Goodwill | 811.45M | 816.38M | 780.03M | 778.91M | 769.51M | 523.95M | 529.46M | 524M | 448M | 441.36M | 439.81M | 383.91M | 383.65M | 28.52M | 28.52M | 28.52M | 28.52M | 26.66M | 26.66M | 26.36M | 25.25M | 13.33M | 6.37M | 6.37M | 6.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 156.46M | 163.29M | 165.05M | 191.21M | 213.29M | 94.67M | 121.66M | 143.92M | 105.98M | 128.07M | 147.48M | 134.91M | 160.39M | 15.13M | 18.86M | 22.71M | 26.65M | 26.5M | 29.99M | 33.45M | 6.91M | 2.15M | 637K | 1.27M | 2.24M | 9.55M | 4.09M | 5.1M | 6.1M | 2.9M | 2M |
| Long-Term Investments | 7.43M | 3.72M | 3.86M | 4.08M | 4.29M | -46.45M | -51.36M | -56.43M | 4.9M | 4.8M | 4.55M | -810K | -1.39M | -893K | -47.97M | -556K | -552K | -891K | 0 | -515K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 18.69M | 14.42M | 13.46M | 12.87M | -51.96M | 11.67M | 11.33M | 8.62M | -42.49M | -48.28M | 1.87M | 5.06M | 4.34M | 541K | 47.91M | 474K | 420K | 60K | 59K | 61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 0 |
| Total Assets | 1.69B | 1.71B | 1.58B | 1.6B | 1.62B | 1.2B | 1.17B | 1.16B | 981.36M | 963.64M | 948.63M | 881.22M | 861.27M | 376.87M | 312.55M | 271.72M | 228.62M | 187.81M | 154.47M | 154.42M | 92.33M | 75.14M | 60.41M | 56.91M | 53.3M | 44.48M | 23.22M | 22M | 22.6M | 17.6M | 15.1M |
| Asset Turnover | 0.63x | 0.61x | 0.61x | 0.58x | 0.58x | 0.67x | 0.60x | 0.56x | 0.66x | 0.62x | 0.58x | 0.63x | 0.63x | 0.89x | 0.99x | 1.07x | 1.12x | 1.17x | 1.50x | 1.14x | 1.09x | 11.17x | 1.12x | 1.09x | 1.13x | 1.04x | 1.43x | 1.35x | 1.27x | 1.63x | 1.75x |
| Asset Growth % | 23.67% | 8.39% | -1.37% | -1.68% | 35.45% | 2.87% | 0.88% | 17.76% | 1.84% | 1.58% | 7.65% | 2.32% | 128.53% | 20.58% | 15.03% | 18.85% | 21.73% | 21.58% | 0.03% | 67.25% | 22.88% | 24.4% | 6.15% | 6.77% | 19.83% | 91.53% | 5.55% | -2.65% | 28.41% | 16.56% | 5.59% |
| Total Current Liabilities | 152.54M | 176.38M | 157.69M | 148.49M | 140.04M | 143.8M | 94.43M | 92.26M | 82.06M | 108.4M | 101.01M | 81.12M | 95.52M | 35.75M | 30.23M | 30.91M | 29.51M | 33.81M | 25.68M | 36.33M | 9.56M | 9.15M | 5.71M | 6.08M | 7.93M | 6.48M | 3.28M | 2.8M | 3.5M | 3.6M | 3.5M |
| Accounts Payable | 0 | 60.42M | 54.74M | 55.5M | 57.32M | 56.24M | 23.74M | 37.27M | 33.79M | 28.45M | 32.51M | 14.71M | 24.35M | 12.39M | 14.28M | 11.53M | 9.76M | 10.88M | 10.34M | 11.19M | 3.01M | 2.56M | 1.47M | 1.25M | 2.78M | 2.88M | 970K | 600K | 1.1M | 2.7M | 2.5M |
| Days Payables Outstanding | 23.74 | 33.09 | 32.36 | 32.66 | 31.61 | 36.93 | 18.06 | 31.46 | 28.07 | 25.59 | 31.87 | 13.97 | 22.38 | 18.87 | 23.59 | 20.44 | 20.11 | 26.03 | 21.02 | 31.6 | 16.42 | 17.19 | 12.27 | 11.24 | 27.49 | 37.32 | 20.65 | 14.04 | 25.74 | 64.41 | 66.61 |
| Short-Term Debt | 33.71M | 3.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35M | 35M | 35M | 35M | 0 | 0 | 1.39M | 1.48M | 6.78M | 4.9M | 10.59M | 0 | 0 | 0 | 1.74M | 1.74M | 1.75M | 0 | 600K | 1.2M | 800K | 700K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40K | 0 | 0 | 0 | 42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 118.83M | 77.18M | 22.89M | 71.54M | 62.15M | 65.63M | 48.6M | 41.46M | 2.26M | 13.85M | 12.09M | 13.46M | 11.42M | 7.86M | 4.14M | 4.29M | 13.56M | 0 | 0 | 5.83M | 4.68M | 4.83M | 2.75M | 389K | 382K | 305K | 521K | 1.6M | 1.2M | 100K | 300K |
| Current Ratio | 2.55x | 2.07x | 1.99x | 2.12x | 2.40x | 2.24x | 2.83x | 2.76x | 2.76x | 1.84x | 1.87x | 2.45x | 1.90x | 7.77x | 7.01x | 5.68x | 4.39x | 2.75x | 2.15x | 1.44x | 3.02x | 3.85x | 5.12x | 3.89x | 2.37x | 2.63x | 3.47x | 3.25x | 2.40x | 2.03x | 1.60x |
| Quick Ratio | 1.59x | 1.33x | 1.16x | 1.38x | 1.54x | 1.61x | 2.08x | 1.85x | 1.94x | 1.28x | 1.30x | 1.88x | 1.38x | 7.07x | 6.32x | 5.08x | 3.86x | 2.34x | 1.50x | 1.01x | 1.98x | 2.92x | 4.01x | 2.91x | 1.46x | 1.77x | 2.69x | 2.29x | 1.57x | 1.33x | 1.06x |
| Cash Conversion Cycle | 100.73 | 89.43 | 90.76 | 81.35 | 85.34 | 76.49 | 86.61 | 92.35 | 84.19 | 84.99 | 79.17 | 69.75 | 71.75 | 61.56 | 59.99 | 55.67 | 58.16 | 55.88 | 60.36 | 74.08 | 79.57 | 45.11 | 83.93 | 84.86 | 87.54 | 91.2 | 89.18 | 98.29 | 84.08 | 34.79 | 25.49 |
| Total Non-Current Liabilities | 256.09M | 273.76M | 267.77M | 394.74M | 546.19M | 178.51M | 243.18M | 319.76M | 207.68M | 238.36M | 326.58M | 336.4M | 373.85M | 9.76M | 9.3M | 8.79M | 11.65M | 6.86M | 14.28M | 25.01M | 7.41M | 5.06M | 4.46M | 11.05M | 12.1M | 12.67M | 362K | 1.3M | 3.3M | 1.7M | 2.2M |
| Long-Term Debt | 33.71M | 175.32M | 190M | 309.57M | 440.57M | 108.57M | 163.57M | 248.57M | 156M | 183.96M | 245.49M | 260.96M | 297.5M | 0 | 3.43M | 23K | 3.43M | 0 | 6.67M | 17.4M | 0 | 0 | 0 | 7.84M | 9.58M | 11.32M | 0 | 700K | 2.6M | 800K | 1.4M |
| Capital Lease Obligations | 40.53M | 12.87M | 14.72M | 16.54M | 16.02M | 7.11M | 6.08M | 4.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 224.2M | 75.45M | 43.72M | 52.05M | 62.78M | 46.45M | 51.36M | 56.43M | 44.31M | 48.55M | 74.2M | 67.22M | 70.4M | 5.88M | 5.87M | 5.98M | 5.64M | 5.03M | 6M | 6.09M | 6.63M | 4.01M | 3.46M | 2.23M | 1.56M | 351K | 225K | 400K | 500K | 500K | 500K |
| Other Non-Current Liabilities | 169M | 10.12M | 19.34M | 16.58M | 26.81M | 16.37M | 22.18M | 9.93M | 7.37M | 5.85M | 6.9M | 6.68M | 5.95M | 3.88M | 0 | 2.79M | 2.58M | 1.82M | 1.61M | 1.53M | 784K | 1.04M | 1M | 985K | 964K | 994K | 137K | 200K | 200K | 400K | 300K |
| Total Liabilities | 408.63M | 450.15M | 425.46M | 543.23M | 686.23M | 322.31M | 337.61M | 412.01M | 289.74M | 346.75M | 427.59M | 417.52M | 469.37M | 45.51M | 39.53M | 39.71M | 41.16M | 40.67M | 39.97M | 61.34M | 16.97M | 14.21M | 10.17M | 17.13M | 20.03M | 19.14M | 3.64M | 4.1M | 6.8M | 5.3M | 5.7M |
| Total Debt | 33.71M | 192.01M | 208.04M | 330.33M | 460.61M | 118.04M | 171.99M | 255.87M | 156M | 218.96M | 280.49M | 295.96M | 332.5M | 3.88M | 3.43M | 1.41M | 4.91M | 6.78M | 11.57M | 27.99M | 0 | 0 | 0 | 9.58M | 11.32M | 13.07M | 0 | 1.3M | 3.8M | 1.6M | 2.1M |
| Net Debt | -39.16M | 117.44M | 158.53M | 265.89M | 394.05M | 14.8M | 87.41M | 190.2M | 101.73M | 178.55M | 241.85M | 211.17M | 282.21M | -204.87M | -141.31M | -113.37M | -72.34M | -39.65M | 8.15M | 25.68M | -5.19M | -13M | -12.73M | 342K | 9.59M | 9.95M | -3.07M | -400K | 2.5M | 900K | 2M |
| Debt / Equity | 0.03x | 0.15x | 0.18x | 0.31x | 0.49x | 0.13x | 0.21x | 0.34x | 0.23x | 0.35x | 0.54x | 0.64x | 0.85x | 0.01x | 0.01x | 0.01x | 0.03x | 0.05x | 0.10x | 0.30x | - | - | - | 0.24x | 0.34x | 0.52x | - | 0.07x | 0.24x | 0.13x | 0.22x |
| Debt / EBITDA | 0.13x | 0.73x | 0.90x | 1.54x | 2.34x | 0.67x | 1.06x | 1.72x | 1.03x | 1.55x | 2.05x | 2.21x | 2.95x | 0.05x | 0.05x | 0.02x | 0.08x | 0.14x | 0.31x | 0.87x | - | - | - | 0.76x | 0.75x | 1.21x | - | 0.19x | 0.58x | 0.30x | 0.47x |
| Net Debt / EBITDA | -0.15x | 0.45x | 0.69x | 1.24x | 2.00x | 0.08x | 0.54x | 1.28x | 0.67x | 1.26x | 1.76x | 1.58x | 2.50x | -2.69x | -2.04x | -1.73x | -1.24x | -0.81x | 0.22x | 0.80x | -0.23x | -0.66x | -0.79x | 0.03x | 0.64x | 0.92x | -0.39x | -0.06x | 0.38x | 0.17x | 0.44x |
| Interest Coverage | 15.23x | 20.48x | 11.07x | 7.07x | 14.03x | 51.99x | 24.97x | 17.19x | 14.01x | 12.73x | 12.41x | 14.21x | 15.98x | 2743.42x | 5985.40x | 676.45x | 558.01x | 195.27x | 30.52x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.29B | 1.26B | 1.15B | 1.05B | 938.28M | 877.01M | 828.23M | 743.67M | 691.62M | 616.88M | 521.03M | 463.7M | 391.9M | 331.36M | 273.01M | 232.01M | 187.47M | 147.14M | 114.51M | 93.08M | 75.36M | 60.93M | 50.23M | 39.78M | 33.27M | 25.33M | 19.58M | 17.9M | 15.8M | 12.3M | 9.4M |
| Equity Growth % | 39.9% | 9.35% | 9.1% | 12.33% | 6.99% | 5.89% | 11.37% | 7.53% | 12.12% | 18.4% | 12.36% | 18.32% | 18.27% | 21.37% | 17.67% | 23.76% | 27.4% | 28.5% | 23.02% | 23.51% | 23.68% | 21.3% | 26.28% | 19.57% | 31.33% | 29.38% | 9.39% | 13.29% | 28.46% | 30.85% | 27.03% |
| Book Value per Share | 39.81 | 38.57 | 35.15 | 32.48 | 28.97 | 26.84 | 25.48 | 22.88 | 21.32 | 19.14 | 16.32 | 14.66 | 12.57 | 10.74 | 8.99 | 7.67 | 6.33 | 5.10 | 4.01 | 3.35 | 2.74 | 2.26 | 1.92 | 1.57 | 1.33 | 1.03 | 0.81 | 0.72 | 0.62 | 0.50 | 0.40 |
| Total Shareholders' Equity | 1.29B | 1.26B | 1.15B | 1.05B | 938.28M | 877.01M | 828.23M | 743.67M | 691.62M | 616.88M | 521.03M | 463.7M | 391.9M | 331.36M | 273.01M | 232.01M | 187.47M | 147.14M | 114.51M | 93.08M | 75.36M | 60.93M | 50.23M | 39.78M | 33.27M | 25.33M | 19.58M | 17.9M | 15.8M | 12.3M | 9.4M |
| Common Stock | 2.14M | 2.14M | 2.17M | 2.15M | 2.15M | 2.15M | 2.16M | 2.16M | 2.15M | 2.13M | 2.12M | 2.1M | 2.06M | 2.02M | 1.96M | 1.94M | 1.92M | 1.87M | 823K | 804K | 788K | 776K | 508K | 327K | 327K | 327K | 327K | 300K | 0 | 0 | 0 |
| Retained Earnings | 1.16B | 1.12B | 997.49M | 897.49M | 814.49M | 732.14M | 656.74M | 590.92M | 528.03M | 464.64M | 388.09M | 344.2M | 295.2M | 251.63M | 214.61M | 181.07M | 147.54M | 118.58M | 94.88M | 77.84M | 63.99M | 53.31M | 43.4M | 36.06M | 30.81M | 23.77M | 18.97M | 15.5M | 12.7M | 9.9M | 7.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | -7.87M | -18.07M | -56K | 0 | 0 | -74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.16M | 0 | -504K | -1.41M | -2.15M | -2.8M | -900K | 0 | 0 | 0 |
| Accumulated OCI | 31.75M | 41.55M | -23.75M | 8.69M | -7.15M | -4.99M | 4.17M | -5.56M | -3.6M | -1.64M | -6.85M | -5.11M | -2.65M | 198K | -759K | -938K | -549K | 153K | -8K | 150K | 193K | -17.93M | -15.35M | -12.82M | -11.02M | -9.19M | -7.86M | -7M | -6M | -5.2M | -7.2M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Regulatory Ethylene Oxide Exposure
According to recent SEC filings, Balchem has significantly strengthened its balance sheet by reducing total debt from $330.3 million in 2023Q4 to just $33.7 million by 2026Q1, signaling a transition toward a net-cash position that provides substantial insulation against potential macroeconomic volatility or future capital requirements.
The consistent reduction in debt levels over the past ten quarters suggests a management team prioritizing fiscal conservatism and balance sheet optionality. This trajectory indicates that the company is effectively utilizing its strong cash flow to deleverage, which may lower the cost of capital and provide a buffer for future strategic investments.
Based on reported financial statements, Balchem's debt-to-equity ratio has compressed from 0.31 in 2023Q4 to a negligible 0.03 in 2026Q1, reflecting a strategic shift that minimizes interest expense and mitigates refinancing risks in an environment of fluctuating interest rates.
The near-elimination of debt suggests that the company is not reliant on external financing to fund its operations or R&D initiatives. This lack of leverage is a key differentiator compared to peers, potentially allowing the firm to maintain its R&D and acquisition pace even if credit markets tighten.
As reported in quarterly balance sheets, goodwill remains a significant component of total assets at $811.5 million as of 2026Q1, representing nearly 48% of the total asset base, which warrants close monitoring for potential impairment risks related to past acquisitions.
The high concentration of goodwill and intangibles reflects the company's history of acquiring specialized intellectual property to bolster its product portfolio. While this supports the competitive moat, investors should monitor whether these assets continue to generate the expected returns on invested capital to justify their carrying values.
Based on the provided data, Balchem maintains a healthy current ratio of 2.55 as of 2026Q1, indicating that the company possesses sufficient short-term assets to cover its immediate obligations without relying on external credit facilities or aggressive working capital management.
The consistent current ratio, which has remained above 2.0 for the majority of the last ten quarters, suggests a stable liquidity profile that supports ongoing operational requirements. This liquidity buffer appears adequate to handle potential regulatory-driven capital expenditures without compromising the company's ability to meet its short-term liabilities.
According to historical balance sheet data, retained earnings have grown steadily from $897.5 million in 2023Q4 to $1.2 billion in 2026Q1, demonstrating that internal capital generation is the primary driver of equity expansion rather than external dilution.
The consistent accumulation of retained earnings underscores the profitability of the underlying business model and the effectiveness of management's capital allocation strategy. This trend suggests that the company is successfully reinvesting its profits to build long-term shareholder value while maintaining a clean capital structure.
Quick answers to the most common questions about buying BCPC stock.
As of 2025, Balchem Corporation (BCPC) had total assets of $1.71B including $365.6M in current assets.
Balchem Corporation (BCPC) carries total debt of $192.0M, offset by $74.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Balchem Corporation (BCPC) has total shareholders' equity (book value) of $1.26B ($38.57 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Balchem Corporation (BCPC) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.